Lambert-eaton myasthenic syndrome. 2009

Maria B Weimer, and Joaquin Wong
Maria B. Weimer, MD Louisiana State University Health Sciences Center, Department of Neurology, 200 Henry Clay Suite 3314, New Orleans, LA 70118, USA. mweime@lsuhsc.edu.

Lambert Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disease. Often, the signs and symptoms of LEMS are mistaken for myasthenia gravis and therefore the workup is misdirected. A physician must look for an occult malignancy when the diagnosis is made and then continue to search for a malignancy for at least 5 years after diagnosis. The diagnosis of LEMS can be confirmed with electrophysiologic studies or with serum calcium channel antibodies. In most patients with LEMS, 3,4-diaminopyridine will improve strength. In patients without malignancy, immunosuppressants do have a role in the treatment of LEMS. Patients and physicians must be aware that certain situations and drugs may exacerbate weakness.

UI MeSH Term Description Entries

Related Publications

Maria B Weimer, and Joaquin Wong
January 1994, Ryoikibetsu shokogun shirizu,
Maria B Weimer, and Joaquin Wong
September 1999, Postgraduate medical journal,
Maria B Weimer, and Joaquin Wong
January 2010, Biomedica : revista del Instituto Nacional de Salud,
Maria B Weimer, and Joaquin Wong
January 2009, BMJ case reports,
Maria B Weimer, and Joaquin Wong
June 2004, Seminars in neurology,
Maria B Weimer, and Joaquin Wong
July 1990, Nihon rinsho. Japanese journal of clinical medicine,
Maria B Weimer, and Joaquin Wong
November 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
Maria B Weimer, and Joaquin Wong
May 2018, Neurologic clinics,
Maria B Weimer, and Joaquin Wong
August 2021, Revista de neurologia,
Maria B Weimer, and Joaquin Wong
September 1998, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Copied contents to your clipboard!